|
AHNAK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.372200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.200260E-03 |
| Normal-vs-Stage2 |
3.632400E-04 |
| Normal-vs-Stage3 |
2.179100E-03 |
| Normal-vs-Stage4 |
7.218300E-03 |
| Stage1-vs-Stage2 |
1.169780E-01 |
| Stage1-vs-Stage3 |
9.625600E-01 |
| Stage1-vs-Stage4 |
9.212400E-01 |
| Stage2-vs-Stage3 |
1.415440E-01 |
| Stage2-vs-Stage4 |
1.925210E-01 |
| Stage3-vs-Stage4 |
9.517400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.297700E-03 |
| Normal-vs-AfricanAmerican |
4.452100E-02 |
| Normal-vs-Asian |
2.678100E-02 |
| Caucasian-vs-AfricanAmerican |
9.434000E-01 |
| Caucasian-vs-Asian |
7.813600E-01 |
| AfricanAmerican-vs-Asian |
9.040200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.57710000000023E-05 |
| Normal-vs-Female |
3.449000E-04 |
| Male-vs-Female |
2.841800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.520500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.036400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.383600E-04 |
| Normal-vs-Age(81-100Yrs) |
8.357600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.524600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.217500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.918200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.883600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.543000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.065000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.368000E-01 |
| Classical-VS-Follicular |
1.62447832963153E-12 |
| Classical-VS-Other |
8.072200E-02 |
| Classical-VS-Normal |
6.084200E-02 |
| Tall-VS-Follicular |
3.10339999998188E-06 |
| Tall-VS-Other |
1.362590E-01 |
| Tall-VS-Normal |
2.932000E-02 |
| Follicular-VS-Other |
3.553600E-01 |
| Follicular-VS-Normal |
1.63946634046397E-12 |
| Other-VS-Normal |
7.763400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89961000000016E-05 |
| Normal-vs-N1 |
1.157640E-03 |
| N0-vs-N1 |
3.366600E-01 |
|
|
